stockfeedai logostocksfeed.ai
REPL
Replimune Group, Inc.
$2.175
USD
+$0.57 (+35.62%)since Apr 13, 2026
REPL

FDA Rejection Sparks Questions On Replimune Drug Approval Path - Replimune Group (NASDAQ:REPL)

Neutral
BENZINGA•Apr 13, 2026, 5:44 PM•By Vandana Singh, Vandana Singh Benzinga Editor
Read Original
FASTREPLPLCE

Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Sess

Neutral
BENZINGA•Apr 13, 2026, 12:02 PM•By Avi Kapoor
Read Original